Cargando…
LGG-20. Defining subgroups in low grade gliomas by their immune and stromal microenvironment
Immunologic treatment options are still uncommon in low grade gliomas, although such therapies might be beneficial for inoperable and aggressive cases. Knowledge on immune and stromal cells in low grade gliomas, which is a mandatory prerequisite for such approaches, is still scarce. We therefore gat...
Autores principales: | Körner, Meik, Spohn, Michael, Schüller, Ulrich, Bockmayr, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164699/ http://dx.doi.org/10.1093/neuonc/noac079.334 |
Ejemplares similares
-
LGG-57. SIGNALLING MECHANISMS IN PAEDIATRIC LOW-GRADE GLIOMA
por: Patel, Ankit, et al.
Publicado: (2020) -
LGG-02. PEDIATRIC LOW-GRADE GLIOMA RISK STRATIFICATION IN THE MOLECULAR ERA
por: Hata, Jessica, et al.
Publicado: (2021) -
LGG-44. PROGNOSTIC SIGNIFICANCE OF IMAGING CHARACTERISTICS IN PEDIATRIC LOW GRADE GLIOMAS
por: Baig, Muhammad, et al.
Publicado: (2020) -
LGG-12. TRAMETINIB FOR PEDIATRIC LOW GRADE GLIOMAS: A SINGLE INSTITUTION EXPERIENCE
por: Barbour, Mustafa, et al.
Publicado: (2020) -
LGG-46. MOLECULAR CHARACTERIZATION OF HEMISPHERIC LOW-GRADE GLIOMAS IN CHILDREN
por: Mišove, Adéla, et al.
Publicado: (2020)